Speaking at the recent ESMO 2023 meeting, Dr Filippo Pietrantonio, Medical Oncologist, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy, discusses important considerations to take into account when treating transgender or gender-diverse cancer patients, as well as the various health disparities they face.